Evaluation of Peak Intraocular Pressure Reduction in the Water-Drinking Test and Safety of Subliminal Subthreshold Laser

Journal of Ocular Pharmacology and Therapeutics · Published 2026-02-04 · DOI 10.1177/10807683261417554

Authors being retrieved — see the publisher record. https://doi.org/10.1177/10807683261417554

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Comparison of Two Preservative-Free Artificial Tears with Sodium Hyaluronate for Relief of Dry Eye Symptoms: A Randomized, Investigator-Masked Study · Journal of Ocular Pharmacology and Therapeutics · 2025 · Same journal
PPARα-Dependent and Independent Mechanisms Are Complexly Involved in the Ameliorative Effect of a Dietary Supplement Containing Lactic Acid Bacteria in a Dry Eye Mouse Model · Journal of Ocular Pharmacology and Therapeutics · 2026 · Same journal
Investigation of Corneal Epithelial Tight Junction Disruption and Barrier Function Impairment Induced by Benzalkonium Chloride · Journal of Ocular Pharmacology and Therapeutics · 2026 · Same journal
Cetalkonium Chloride Induced a Dose-Dependent Toxicity on Corneal Endothelial Cells · Journal of Ocular Pharmacology and Therapeutics · 2025 · Same journal
Effect of pH and Benzalkonium Chloride in Low-Dose Atropine on Pupil Dilation in Dutch Belted Rabbits · Journal of Ocular Pharmacology and Therapeutics · 2026 · Same journal
miR-129-5p Modulates the ZEB1/2 Signaling Axis to Suppress Palmitic Acid-Induced Epithelial–Mesenchymal Transition and Barrier Dysfunction in ARPE-19 Cells · Journal of Ocular Pharmacology and Therapeutics · 2026 · Same journal
Drug-Related Uveitis: A Real-World Study Based on the Food and Drug Administration Adverse Event Reporting System Database · Journal of Ocular Pharmacology and Therapeutics · 2026 · Same journal
Cholesterol Conjugation Strategies to Enhance In Vivo Antisense Oligonucleotide-Mediated Exon Skipping in the Mouse Retina · Journal of Ocular Pharmacology and Therapeutics · 2026 · Same journal
Double-Masked Controlled Trial of H-1337 as a Treatment for Glaucoma and Ocular Hypertension · Journal of Ocular Pharmacology and Therapeutics · 2025 · Same journal
Dose-Dependent Corneal Epithelial and Neural Toxicity of Topical Proparacaine: An In Vivo and In Vitro Study · Journal of Ocular Pharmacology and Therapeutics · 2026 · Same journal